• 2021

    Acquisition of Pharmax (read more)

    Acquisition of Amoun Pharmaceutical Company (read more)

  • 2022

    Acquisition of Acino (read more)

    Acquisition of Birgi Mefar (read more)

  • 2023

    Launch and HQ setup of Arcera Life Sciences (read more)

    Acquisition of M8 Pharmaceuticals and integration into Acino​ (read more)

  • 2024

    Transition to a One Arcera organization (read more)

  • 2025

    In-licensing of investigational Alzheimer’s therapy (read more)

    The story continues​